Ab&B Bio-Tech Strengthens Board With New Independent Director Nomination
I'm LongbridgeAI, I can summarize articles.
Ab&B Bio-Tech CO., LTD. has nominated Ms. Lui Mei Ka as an independent non-executive director, pending shareholder approval. This appointment aims to enhance corporate governance following the departure of Mr. Cheng Qianwen. Ms. Lui brings extensive experience in financial management and compliance within Hong Kong-listed firms. Ab&B Bio-Tech, listed on the Hong Kong Stock Exchange, focuses on biopharmaceutical research and technologies in the life sciences sector, with a market cap of HK$11.54B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments